2022-07-06-世界卫生组织-Immunization_Saint_Kitts_and_Nevis_2022_country_profile_16页_349kb

报告摘要

Immunization Coverage Estimates for Saint Kitts and Nevis (2010-2021)

This summary presents WHO and UNICEF's estimates of national immunization coverage for key vaccines in Saint Kitts and Nevis, based on data from 2010 to 2021.

Estimates are derived primarily from national reporting data and adjusted using demography and population data, with varying levels of confidence (GoC). The grade of confidence reflects the empirical support and does not signify data quality judgments.

Key Vaccines Covered

BCG: Highest estimated coverage was 99% in 2019.
DTP1: Coverage fluctuated between 97% and 99%.
DTP3: Mostly high coverage (>98%) except in 2015.
Pol3: High coverage, with a slight dip in 2015.
IPV1: Introduced in 2016, Began estimates in 2021.
MCV1: Coverage declined slightly from 2019 onwards.
MCV2: Coverage generally high but was challenged in some years.
HepB Birth Dose: Introduced in 2015, showing increasing coverage.
HepB3: Coverage stable and high (>94%).
Hib3: Coverage generally high (>94%).
PcV3 / RotaC: No data estimates provided.

Notable Trends and Challenges

Stability: Coverage for many vaccines (e.g., BCG, DTP3, HepB3) remained strong, often above 95%.
Declines: MCV1 showed a slight decline starting mid-decade. Pol3 dipped in 2015 due to a stock-out.
Variability: Some vaccines exhibited fluctuations (e.g., Pol3, MCV1, MCV2).
Data Quality Notes: Some estimates were challenged due to calculation methods or reported program issues (e.g., stock-outs, observed trends).
Recommendations: WHO/UNICEF advises confirming reported levels with high-quality surveys where possible.

Coverage estimates should be used cautiously, considering their limitations and the specific context. Data sources and GoC can be found in the referenced URLs.

展开完整摘要